Calling All Innovators
Your inventive idea could help the growing number of patients who rely on plasma-derived immunoglobulin.
At the Heart of Innovation for Patients
Marburg, Germany’s vibrant R&D ecosystem creates hope for patients and CSL Behring’s future.
A Research Catalyst in Switzerland
A new partnership between CSL Behring and Biopôle takes shape, pairing the global biotech with one of the most dynamic life s…
The Fight Against COVID-19
Two CSL leaders talk with BioSpace.com about the company’s ongoing work all over the world.
Australia's “60 Minutes” Reports on CSL & COVID-19
About producing AstraZeneca's COVID-19 vaccine, Seqirus leader says: “I’m just incredibly proud that we can play such an impo…
CEO Paul Perreault discusses COVID-19 medical innovation with health care leaders from US and Australia.
Protecting Public Health During a Pandemic
A leader with Seqirus, a major flu vaccine producer, talks about the twin threats of influenza and COVID-19.
Three Rules for a Post-COVID World
“We’re all disrupters now,” says futurist Mike Walsh, who addressed 500 CSL leaders on 2021 and what comes next.
Industry Partnership Fuels Research, Advocacy
PhRMA membership expands CSL Behring’s opportunity for cooperation between industry leaders.
Innovating With Engineering Students
CSL Behring in Kankakee, Illinois, partners with local university to optimize the recovery of alcohol used in manufacturing.
Take a Virtual Lab Tour
Go behind the scenes in Marburg, Germany, to learn how scientists remove pathogens from medicines to make them safe for patie…